Joseph T. Kotsybar, Pharm.D. (he/him/his)

Regulatory Health Project Manager
US Food and Drug Administration

Poster(s):

• (M1130-04-24) The Impact of Cyclodextrin on Fasting and Fed Bioequivalence Studies in Solid Oral Immediate-Release Drug Products
  Monday, October 17, 2022

  11:30 AM – 12:30 PM ET